Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px
Document › Details

Intercell AG. (5/8/12). "Press Release: Intercell AG Announces Q1 2012 Results and Operational Update. Solid Ixiaro/Jespect Sales Revenues up by 36.4% to EUR 4.6m in Q1 2012 Compared to Q1 2011". Vienna.

Organisation Organisation Intercell AG (VSE: ICLL)
  Today Valneva Austria GmbH
  Group Valneva (Group)
Products Product Ixiaro®
  Product 2 vaccine technology
     


   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Valneva (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px




» top